Lung Ultrasound for Physiotherapy in Hospitalized Patients With Respiratory Complications

The Value of Point-of-care Lung Ultrasound for Physiotherapy in Hospitalized Patients With Acute Respiratory Symptoms

This study aims to evaluate the relevance of using point-of-care lung ultrasound (LUS) in modifying the physiotherapist's treatment plan for patients hospitalized in a general ward.

Study Overview

• Status: Recruiting
• Conditions: Respiratory Complication

Detailed Description

Hospitalized patients often confront respiratory issues stemming from diverse causes, such as pneumonia. Physiotherapists rely on a range of clinical and imaging data to inform their treatment decisions. Yet, they face challenges due to the absence of readily accessible, sensitive, specific, and reliable measurements to tailor the most effective physical therapeutic interventions based on individual clinical scenarios. Point-of-care Lung Ultrasound (LUS) holds promise in addressing these existing gaps.

This study aims to evaluate the impact of integrating LUS into clinical practice by comparing physiotherapists' initial clinical assessments and treatment plans with those made after incorporating LUS findings in patients admitted to a general ward.

• Study Type: Observational
• Enrollment (Estimated): 30

Contacts and Locations

• Study Contact: Name: William Poncin; Phone Number: +3227642316; Email: william.poncin@uclouvain.be

Study Locations

• Belgium
  • Brussels Capital
    • Brussels, Brussels Capital, Belgium, 1200
      • Recruiting
      • Cliniques Universitaires Saint-Luc
      • Contact: William Poncin, PhD; Phone Number: +3227642316; Email: william.poncin@uclouvain.be

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: N/A

• Sampling Method: Non-Probability Sample

Study Population

Hospitalization in a general ward in the University Hospital Saint-Luc.

Description

Inclusion Criteria:

• Hospitalization in a general ward
• Acute respiratory symptoms (< 48h)
• Chest X-ray available within 24h before or after the use of LUS

Exclusion Criteria:

• Any conditions precluding the use of LUS (thoracic skin lesions, thoracic bandage, subcutaneous emphysema)
• Inability to understand instructions due to cognitive impairment or due to language barrier

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Percentage of change of treatment plan	Relative change of treatment plan after the results of LUS in relation to the total number of events	Before and Immediately after the use of LUS (10-min interval)

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Agreement between the events observed on LUS and the events observed on Chest X-Ray	Number of concordant findings between LUS and Chest X-Ray. Each pair of tests will be rated as "positive" (same findings are observed between LUS and Chest X-Ray) or "negative" (findings are different).	At baseline

Collaborators and Investigators

• Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Study record dates

Study Major Dates

• Study Start (Actual): May 10, 2024
• Primary Completion (Estimated): December 30, 2026
• Study Completion (Estimated): December 30, 2026

Study Registration Dates

• First Submitted: May 8, 2024
• First Submitted That Met QC Criteria: May 11, 2024
• First Posted (Actual): May 14, 2024

Study Record Updates

• Last Update Posted (Actual): April 27, 2026
• Last Update Submitted That Met QC Criteria: April 22, 2026
• Last Verified: April 1, 2026

More Information

Terms related to this study

• Other Study ID Numbers: LUS-physio

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No